Cargando…

Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2

SARS-CoV-2, the newly identified human coronavirus causing severe pneumonia pandemic, was probably originated from Chinese horseshoe bats. However, direct transmission of the virus from bats to humans is unlikely due to lack of direct contact, implying the existence of unknown intermediate hosts. An...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Ye, Zhao, Yuan-Bo, Wang, Qiong, Li, Jin-Yan, Zhou, Zhi-Jian, Liao, Ce-Heng, Ge, Xing-Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Institut Pasteur. Published by Elsevier Masson SAS. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156207/
https://www.ncbi.nlm.nih.gov/pubmed/32199943
http://dx.doi.org/10.1016/j.micinf.2020.03.003
_version_ 1783522167121510400
author Qiu, Ye
Zhao, Yuan-Bo
Wang, Qiong
Li, Jin-Yan
Zhou, Zhi-Jian
Liao, Ce-Heng
Ge, Xing-Yi
author_facet Qiu, Ye
Zhao, Yuan-Bo
Wang, Qiong
Li, Jin-Yan
Zhou, Zhi-Jian
Liao, Ce-Heng
Ge, Xing-Yi
author_sort Qiu, Ye
collection PubMed
description SARS-CoV-2, the newly identified human coronavirus causing severe pneumonia pandemic, was probably originated from Chinese horseshoe bats. However, direct transmission of the virus from bats to humans is unlikely due to lack of direct contact, implying the existence of unknown intermediate hosts. Angiotensin converting enzyme 2 (ACE2) is the receptor of SARS-CoV-2, but only ACE2s of certain species can be utilized by SARS-CoV-2. Here, we evaluated and ranked the receptor-utilizing capability of ACE2s from various species by phylogenetic clustering and sequence alignment with the currently known ACE2s utilized by SARS-CoV-2. As a result, we predicted that SARS-CoV-2 tends to utilize ACE2s of various mammals, except murines, and some birds, such as pigeon. This prediction may help to screen the intermediate hosts of SARS-CoV-2.
format Online
Article
Text
id pubmed-7156207
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Institut Pasteur. Published by Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-71562072020-04-15 Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2 Qiu, Ye Zhao, Yuan-Bo Wang, Qiong Li, Jin-Yan Zhou, Zhi-Jian Liao, Ce-Heng Ge, Xing-Yi Microbes Infect Article SARS-CoV-2, the newly identified human coronavirus causing severe pneumonia pandemic, was probably originated from Chinese horseshoe bats. However, direct transmission of the virus from bats to humans is unlikely due to lack of direct contact, implying the existence of unknown intermediate hosts. Angiotensin converting enzyme 2 (ACE2) is the receptor of SARS-CoV-2, but only ACE2s of certain species can be utilized by SARS-CoV-2. Here, we evaluated and ranked the receptor-utilizing capability of ACE2s from various species by phylogenetic clustering and sequence alignment with the currently known ACE2s utilized by SARS-CoV-2. As a result, we predicted that SARS-CoV-2 tends to utilize ACE2s of various mammals, except murines, and some birds, such as pigeon. This prediction may help to screen the intermediate hosts of SARS-CoV-2. Institut Pasteur. Published by Elsevier Masson SAS. 2020 2020-03-19 /pmc/articles/PMC7156207/ /pubmed/32199943 http://dx.doi.org/10.1016/j.micinf.2020.03.003 Text en © 2020 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Qiu, Ye
Zhao, Yuan-Bo
Wang, Qiong
Li, Jin-Yan
Zhou, Zhi-Jian
Liao, Ce-Heng
Ge, Xing-Yi
Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2
title Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2
title_full Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2
title_fullStr Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2
title_full_unstemmed Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2
title_short Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2
title_sort predicting the angiotensin converting enzyme 2 (ace2) utilizing capability as the receptor of sars-cov-2
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156207/
https://www.ncbi.nlm.nih.gov/pubmed/32199943
http://dx.doi.org/10.1016/j.micinf.2020.03.003
work_keys_str_mv AT qiuye predictingtheangiotensinconvertingenzyme2ace2utilizingcapabilityasthereceptorofsarscov2
AT zhaoyuanbo predictingtheangiotensinconvertingenzyme2ace2utilizingcapabilityasthereceptorofsarscov2
AT wangqiong predictingtheangiotensinconvertingenzyme2ace2utilizingcapabilityasthereceptorofsarscov2
AT lijinyan predictingtheangiotensinconvertingenzyme2ace2utilizingcapabilityasthereceptorofsarscov2
AT zhouzhijian predictingtheangiotensinconvertingenzyme2ace2utilizingcapabilityasthereceptorofsarscov2
AT liaoceheng predictingtheangiotensinconvertingenzyme2ace2utilizingcapabilityasthereceptorofsarscov2
AT gexingyi predictingtheangiotensinconvertingenzyme2ace2utilizingcapabilityasthereceptorofsarscov2